AIF Protein
Overview
Apoptosis-Inducing Factor (AIF) is a mitochondrial flavoprotein that functions as a critical mediator of programmed cell death and cellular bioenergetics. Encoded by the AIFM1 gene (Apoptosis-Inducing Factor Mitochondrial 1) located on the X chromosome, AIF is a 67 kDa protein containing a flavin adenine dinucleotide (FAD) cofactor. Originally characterized as a pro-apoptotic factor capable of triggering cell death, AIF has emerged as a multifunctional protein with roles in both pathological and physiological processes. The protein localizes primarily to the intermembrane space of mitochondria, where it exists as a tightly bound component of the oxidative phosphorylation system. Under normal conditions, AIF remains sequestered within mitochondria, but upon cellular stress, it translocates to the nucleus and cytoplasm to execute various cellular functions.
Function and Biology
AIF possesses dual roles as both a bioenergetic enzyme and a death-effector protein. In its physiological capacity, AIF functions as an NADH oxidase, participating in oxidative phosphorylation and the maintenance of cellular ATP production. This enzymatic activity supports mitochondrial respiratory chain function and contributes to cellular energy metabolism. The FAD cofactor enables AIF to shuttle electrons, integrating it into the mitochondrial electron transport system.
...AIF Protein
Overview
Apoptosis-Inducing Factor (AIF) is a mitochondrial flavoprotein that functions as a critical mediator of programmed cell death and cellular bioenergetics. Encoded by the AIFM1 gene (Apoptosis-Inducing Factor Mitochondrial 1) located on the X chromosome, AIF is a 67 kDa protein containing a flavin adenine dinucleotide (FAD) cofactor. Originally characterized as a pro-apoptotic factor capable of triggering cell death, AIF has emerged as a multifunctional protein with roles in both pathological and physiological processes. The protein localizes primarily to the intermembrane space of mitochondria, where it exists as a tightly bound component of the oxidative phosphorylation system. Under normal conditions, AIF remains sequestered within mitochondria, but upon cellular stress, it translocates to the nucleus and cytoplasm to execute various cellular functions.
Function and Biology
AIF possesses dual roles as both a bioenergetic enzyme and a death-effector protein. In its physiological capacity, AIF functions as an NADH oxidase, participating in oxidative phosphorylation and the maintenance of cellular ATP production. This enzymatic activity supports mitochondrial respiratory chain function and contributes to cellular energy metabolism. The FAD cofactor enables AIF to shuttle electrons, integrating it into the mitochondrial electron transport system.
Beyond its metabolic functions, AIF plays a central role in triggering programmed cell death. Following pro-apoptotic stimuli—including DNA damage, oxidative stress, or withdrawal of survival signals—AIF undergoes proteolytic cleavage by calpains and cathepsins. This processing generates a truncated form (tAIF) approximately 57 kDa in size. The truncated form loses its FAD cofactor binding capacity and acquires potent pro-death activity. Following cleavage, AIF translocates from mitochondria across the outer mitochondrial membrane into the cytoplasm, then enters the nucleus where it directly binds to DNA and associates with various nuclear factors to orchestrate large-scale DNA fragmentation and chromatin condensation characteristic of apoptosis.
Role in Neurodegeneration
AIF dysfunction contributes significantly to multiple neurodegenerative diseases through both excessive activation and loss of function. Mutations in AIFM1 cause progressive neurodegeneration in humans, resulting in conditions characterized by progressive neuronal death. The protein's involvement in apoptotic pathways makes it a key player in diseases where excessive neuronal death occurs, including Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS).
In Parkinson's disease, dopaminergic neuronal death involves AIF-mediated apoptosis triggered by oxidative stress and mitochondrial dysfunction. Similarly, in Alzheimer's disease, amyloid-beta accumulation and tau pathology trigger oxidative stress that activates AIF-dependent cell death pathways. ALS-linked mutations in SOD1 and other proteins compromise mitochondrial integrity and facilitate AIF release. Paradoxically, reduced AIF expression or function impairs mitochondrial bioenergetics, potentially contributing to neuronal vulnerability through compromised energy metabolism.
Molecular Mechanisms
AIF-mediated neuronal death involves several interconnected mechanisms. Mitochondrial outer membrane permeabilization (MOMP) triggered by pro-apoptotic Bcl-2 family members (Bax and Bak) permits AIF release. Once in the nucleus, AIF cooperates with cyclophilin A and other nuclear partners to promote large-scale chromatin fragmentation independent of caspase activation, a process termed caspase-independent apoptosis. AIF also participates in autophagy-related neuronal death pathways and can amplify inflammatory responses through interaction with pattern recognition receptors.
The protein's vulnerability to oxidative modification makes it sensitive to redox imbalance, a hallmark of neurodegenerative diseases. Excessive free radical production can trigger premature AIF processing and release, while insufficient AIF function impairs compensatory mitochondrial quality control mechanisms.
Clinical and Research Significance
AIFM1 mutations cause X-linked neurodegeneration, with clinical presentations including progressive encephalomyopathy, developmental delay, and early-onset neuronal loss. Research targeting AIF modulation represents a potential therapeutic strategy, with approaches including calpain inhibition to prevent AIF cleavage, antioxidant therapy to preserve mitochondrial integrity, and gene replacement strategies for AIFM1 mutations.
- [[Mitochondrial dysfunction in neurodegeneration]]
- [[Apoptosis and caspases]]
- [[Bcl-2 family proteins]]
- [[Cyclophilin A]]
- [[Oxidative stress]]
- [[MOMP and neuronal death]]
- [[X-linked neurodegeneration]]
AlphaFold Structure
AlphaFold DB provides a predicted structure for AIFM1 / UniProt O95831 (model version 6): https://alphafold.ebi.ac.uk/entry/O95831.
AlphaFold reports a mean pLDDT confidence score of 85.81, indicating confident backbone placement for much of the model, with lower-confidence regions possible.
InterPro annotations highlight FAD/NAD-linked reductase, dimerisation domain superfamily homologous superfamily (478-613); FAD/NAD(P)-binding domain domain (136-461); Mitochondrial apoptosis-inducing factor, C-terminal domain domain (465-594).
PDB coordinates: https://alphafold.ebi.ac.uk/files/AF-O95831-F1-model_v6.pdb mmCIF coordinates: https://alphafold.ebi.ac.uk/files/AF-O95831-F1-model_v6.cif.
Use the prediction as structural context for target assessment; local low-pLDDT segments may reflect disorder, flexible linkers, or unresolved domain orientation rather than a stable fold.